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Introduction
Hemodynamic assessment is one of the cornerstones of 
critical care medicine, as hemodynamic alterations may 
become life-threatening in minutes. Assuring normal 
hemodynamic values is therefore mandatory to allow one 
to buy time for patient healing. Th e problem arises when 
we have to deﬁ ne normal hemodynamics in critically ill 
patients. If we are able to deﬁ ne normal hemodynamics, 
the target values for therapy will follow. In this brief 
opinion paper we will limit ourselves to the macro hemo-
dynamics and we will discuss the determinants of hemo-
dynamic impairment, the limits of normal, impaired and 
failing hemodynamics, and the volume therapy to be 
applied.
Determinants of hemodynamic impairment
We believe the best approach to this issue is the one 
proposed by Schrier [1], who  – based on a series of 
studies [2,3] – ﬁ nally introduced a unifying hypothesis to 
explain the hemodynamic impairment associated with 
diﬀ erent diseases or syndromes. His approach, slightly 
modiﬁ ed, is presented in Figure 1, which summarizes the 
hemodynamic determinants, the neuro-endocrinal signal-
ing and the body response. In this framework we may 
ﬁ rst consider which variables are independent. Th ese 
variables belong to three categories: the heart (con-
tractility and heart rate), the vascular tone and, ﬁ nally, 
the intravascular volume. In a given disease or syndrome 
one or more of these variables may be aﬀ ected. As an 
example, acute myo cardial infarction is paradigmatic of 
the problems relative to heart contractility and/or rate. A 
primary altera tion of the vascular tone is typical of 
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cirrhosis and septic syn drome. A decreased intravascular 
volume is typical of hemorrhage. In critically ill patients 
more than one variable may be altered at the same time, 
as in sepsis where the impairment of heart contractility 
and the decrease of intravascular volume due to capillary 
leakage may be associated with the decrease of the 
primary artery vessel tone.
We believe that physicians approaching the hemo-
dynamic status of a given patient should ﬁ rst consider 
which independent determinants are more probably 
altered. Of interest to note, however, is that, among the 
primary determinants, the heart rate is the only one 
always assessed in clinical practice. Th e contractility 
measured by echocardio graphy is occasionally assessed 
while the vascular tone and the intravascular volume are 
not measured. One must note that the variables usually 
evaluated to assess hemo dynamics and volemia, such as 
pressures and ﬂ ows, are dependent variables that, when 
altered, may recognize diﬀ erent causes. Th e identiﬁ cation 
of or, at least, the esti mate of which of the independent 
hemodynamic deter mi nants is altered makes the therapy 
a logical conse quence. Unfortunately, independent of the 
altered variable, the ﬁ rst intervention is usually volume 
replacement. A typical example is represented by 
hypotension following the induction of anesthesia. In this 
case the primary cause of hemodynamic impairment is 
the pharmaco logically-induced decrease of the vessel 
tone but the correction is usually performed by volume 
infusion.
Th e baroreceptors, located in the carotid and aortic 
arch [4], sense the underﬁ lling of the arterial tree (which 
in a normal situation contains 15% of the intravascular 
blood volume). Th is underﬁ lling may be caused either by 
a decreased intrathoracic volume or cardiac output, as 
typically occurs during hemorrhage or heart failure, or by 
arterial vasodilation, as may occur in cirrhosis or sepsis. 
Interestingly, one must bear in mind that the concept of 
arterial tree underﬁ lling, which, in some way, recalls the 
concept of eﬀ ective circulating blood volume [5,6], may 
co-exist either with hypovolemia or with hypervolemia, 
as most of the expanded blood volume may be conﬁ ned 
in the venous tract, which acts as a capacitive reservoir. 
Figure 1. Independent variables and the sequence of events leading to water and sodium retention.
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Whatever the cause of the arterial tree underﬁ lling, the 
body response is similar and primarily consists of activa-
tion, via baroreceptors, of the renin–angiotensin–aldo-
sterone system and the nonosmotic release of vasopressin 
[7]. As shown in Figure 1 other factors may be activated, 
and a counter-regulation may occur. It is important, 
however, to realize that the primary body response is 
directed towards the integrity of the arterial circulation, 
by maximizing, through the kidneys, the reabsorption of 
salt and water, while increasing the arterial pressure. 
Th ere are several elements in favor of this unifying hypo-
thesis, as recently reviewed [7]. Here it is suﬃ  cient to say 
that diﬀ erent diseases or syndromes in which underﬁ lling 
may occur, with or without plasma expansion, present 
increased renin, angiotensin and aldosterone levels as 
well as an increase of vasopressin (anti-diuretic hormone) 
despite a frequently associated hypo-osmolarity. In 
general, we believe that the hemodynamic problem and, 
possibly, the therapeutic interventions may be better 
understood if considered in this framework.
Normal hemodynamic, hemodynamic impairment 
and hemodynamic failure
Th e concept of normal hemodynamics is not easy to 
deﬁ ne in critically ill patients. In general, we believe that 
hemodynamics is adequate when the oxygen delivery to 
the tissues is suﬃ  cient to maintain an aerobic meta-
bolism. Th is may occur in critically ill patients at hemo-
dynamic values greater than or lower than the values 
considered normal in healthy subjects at rest. As an 
example, in cases of decreased hemoglobin content and/
or its oxygen saturation, a frequent ﬁ nding in the ICU, or 
if hypermetabolism is present, the cardiac output must 
be greater than normal to provide adequate oxygen 
transport. In contrast, when the metabolic requirements 
are reduced, as may occur in critically ill patients during 
deep sedation or paralysis, the aerobic metabolism may 
be satisﬁ ed with a hemodynamic set of values lower than 
those considered normal in healthy subjects. In other 
words, the normality of hemodynamics should not be 
judged considering the hemodynamic values per se, but 
instead the body response. When the body senses its 
hemodynamic set as adequate, the baroreceptors may be 
activated or not activated. If the easily measured variables 
such as heart rate, urinary output and sodium 
concentration in the urine remain in the range found in 
normal subjects, we may assume that the hemodynamics 
is normal and, obviously, adequate.
In the presence of abnormal hemodynamic values, 
either greater or lower than normal, the hemodynamics 
may be still adequate if it guarantees an aerobic metabo-
lism. Th is metabolism is obtained by activating all of the 
homeostatic mechanisms described above. Th e hemo dy-
namics then becomes inadequate (hemodynamic failure) 
only when signs of anaerobic metabolism appear, despite 
the full activation of the mechanisms normally operating 
to maintain homeo stasis. Th e most recog niza ble and easy 
measurable output of such mecha nisms are water and 
sodium retention [1] as judged at least 6  hours after 
withdrawal of diuretic therapy (too often misused in 
intensive care). Th is response, at least in the early phase, 
should not be confused with kidney failure. On the 
contrary, the response may be a sign of the maximal 
response of a normal kidney activated by the sympathetic 
system and subjected to vasopressin. What is not usually 
realized is the speed of the change in sodium urine 
concentration when the system is activated [8]. Figure 2, 
as an example, presents the electro lyte changes during 
controlled hemorrhage. As shown, the kidney reacts to 
the blood volume decrease by retaining sodium earlier 
than signiﬁ cant changes in mean arterial pressure may be 
detected.
If the underﬁ lling is caused by decreased blood volume 
or cardiac output, the water and sodium retention is 
generally associated with an increased tissue oxygen 
extraction, as indicated by a decrease in central venous 
oxygen saturation (ScvO2). Th is is, in our opinion, a 
reasonable surrogate of the mixed venous saturation 
[9,10]. We may express ScvO2 as a function of its 
determinants according to the following formula:
ScvO2 = SaO2 – (VO2/Q)×1/Hb
As shown, central venous saturation depends on the 
arterial oxygenation (SaO2), on the appropriate match 
between oxygen consumption/metabolic requirement 
(VO2) and on cardiac output (Q), as well as on the oxygen 
carrier (Hb). All determinants of oxygen transport, as 
well as the metabolic rate, may inﬂ uence the central 
venous saturation, which is an extremely sensitive, 
although not speciﬁ c, indicator of changes in respiratory 
function (SaO2), metabolism (VO2), cardiac output (Q) 
and oxygen carrier (Hb). Th e physiological meaning of 
ScvO2 may also be expressed as:
ScvO2 = 1 – VO2/DO2
Th is equation indicates that oxygen venous saturation 
reﬂ ects the residual amount of oxygen in the venous side 
after consumption (VO2) of part of the oxygen delivered 
(DO2). In normal conditions, at rest, the amount of 
oxygen extracted from the oxygen delivered is about 25% 
(VO2/DO2). Th e ScvO2 is therefore around 75%. Th e 
arbitrary recommended threshold of ScvO2 used in 
several studies and in guidelines for sepsis treatment is 
70% [11-14]. One must note, however, that ScvO2 lower 
than the threshold is not necessarily associated with 
anaerobic metabolism.
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As an example in healthy subjects during physical 
exercise, ScvO2 may decrease to 40% while maintaining 
aerobiosis, because in this condition cardiac output 
remarkably increases. Th e most frequent reason for a 
decrease in ScvO2 in the ICU is cardiac failure. In the 
framework of the unifying arterial tree underﬁ lling 
hypothesis, the asso cia tion between sodium/water reten-
tion and low ScvO2 is a strong indicator of underﬁ lling 
due to low ﬂ ow and/or hypovolemia, as typically ob-
served during heart failure, hemorrhage and dehydration. 
In contrast, when the underﬁ lling is due to the arterial 
vasodilatation associated with volume expansion or 
elevated cardiac output, as in cirrhosis or in some phases 
of sepsis, ScvO2 may be higher than 70 to 75%. Th erefore, 
it is important to realize that even normal or higher than 
normal ScvO2 may be associated with abnormalities of 
hemodynamics, as assessed by activation of the renin–
angiotensin–aldo sterone system and vasopressin release. 
Considering water/sodium retention and hypo-ScvO2 or 
hyper-ScvO2 together may therefore indicate whether the 
arterial tree underﬁ lling is primarily due to low heart 
contractility/hypovolemia or vasodilatation, respectively. 
Obviously this is an oversimpliﬁ  ca tion of the problem, 
but we believe that this approach may provide a 
reasonable framework when considering the hemo dy-
namic set in a given patient.
When all of the compensatory mechanisms are over-
come, the hemodynamic failure is overt and its marker is 
the appearance of metabolic acidosis associated with 
increased plasma lactate concentration. We believe that 
the best approach to understand the relationship between 
metabolic acidosis and lactate in tissue hypoxia has been 
provided by Hochachka and Mommsen [15], who 
elegantly showed how lactate production and ATP 
hydrolysis are coupled and must be considered together. 
Here it is enough to say that the appearance of acidosis 
indicates the energy failure of a group of cells that, in the 
absence of correction, may result in cellular death after a 
few hours.
Figure  3 reports the impressive relationship between 
metabolic acidosis and mortality in a general population 
of critically ill patients. In contrast, elevated metabolic 
alkalosis, usually caused by diuretic therapy, is not asso-
cia ted with increased mortality. Beyond pH, several 
Figure 2. Sodium excretion and mean arterial pressure during controlled hemorrhage and reinfusion. The amount of sodium excreted 
(computed as the product of sodium concentration and urine amount) in 30 minutes (black circles) and the mean arterial pressure (MAP; grey 
triangles) during controlled hemorrhage and reinfusion (grey area plot) in an experimental swine model. Vertical grey dashed lines indicate the end 
of baseline/beginning of hemorrhage, end of hemorrhage/beginning of reinfusion and end of reinfusion. As shown, the kidney reacts to the blood 
volume decrease by retaining sodium and reducing urine volume earlier than signifi cant changes in MAP may be detected. Courtesy of Dr A Protti.
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approaches have been proposed to assess the hemo-
dynamic failure [16,17], such as base excess, lactate, 
decreased strong ion diﬀ erence (SID), increased anion 
gap, increased venous to arterial diﬀ erence in partial 
pressure of carbon dioxide (PCO2) and its ratio to the 
arterial–venous oxygen content. All these variables, 
however, are just diﬀ erent facets of the same reality; that 
is, the perturbation of the acid–base equilibrium due to 
nonvolatile acid load, originating from suﬀ ering cells 
(lactate) or dead cells (intracellular strong acid content is 
higher than plasma content). In mammalians, when 
metabolic acidosis starts due to the hemodynamic failure, 
the time for correction is limited before irreversible 
mitochondrial damages and cell death occurs.
Treatment target
Th e ultimate goal of the intervention on hemodynamics 
is to guarantee the maintenance of full aerobic meta bo-
lism. Th e hemodynamic correction may therefore be 
considered a symptomatic treatment allowing buying 
time for the cure of the underlying disease. According to 
Figure 1, the most rational therapy to correct the hemo-
dynamic alterations should be addressed to the correc-
tion of the pathogenetic mechanisms; that is, heart 
contractility/rate, vascular tone or intravascular volume. 
In clinical practice, independent of the variable primarily 
altered, the ﬁ rst intervention is usually the volume 
replace ment, according to the following sequence: ﬁ rst, 
volume; second, cardioactive drugs; and third, blood.
Th e most popular hemodynamic target, at least in 
sepsis, is to reach or maintain ScvO2 >70% [13,14]. Th is 
has been popularized by Rivers and colleagues’ study 
[12], in which the septic patients at entry had baseline 
ScvO2 <50%. Targeting ScvO2 of 70%, Rivers and colleagues 
obtained a signiﬁ cant improvement of the survival rate. 
In contrast, in a previous study, we could not ﬁ nd any 
diﬀ erence in outcome in the same kind of patients with a 
similar target [11]. Th e baseline SvO2 of these patients, 
however, was 68%  – remarkably diﬀ erent from that in 
Rivers and colleagues’ study. We also found that targeting 
SvO2 of 70% was analogous to target a cardiac index of 
2.5  l/minute/m2. Th e most plausible explanation for the 
discre pancy between these studies is the time of 
intervention: earlier in Rivers and colleagues’ study, in 
the emergency room; and later in our study, after 
admission to the ICU. However, one should note that all 
these studies focused on problems associated with a low 
SvO2 state, ignoring the possible hemodynamic 
derangements occurring in high SvO2 states.
Volume replacement
Fluid challenge
Volume replacement treatment requires assessment of 
the patient’s intravascular volume status (cardiac preload) 
and the likelihood of responsiveness (that is, increase the 
stroke volume) to a ﬂ uid challenge test. In fact, data 
suggest that about 50% of the critically ill patients 
positively respond to challenge tests [18-20]. Multiple 
tools have been suggested as indicators for ﬂ uid adminis-
tration, most of them as predictors of response and as 
targets [21]. Clinical signs, such as thirst, skin turgor, 
blood pressure, urine output, and so forth, are unreliable 
indexes of intravascular volume status. Similarly, cardiac 
ﬁ lling pressures (central venous pressure (CVP) and 
pulmo nary artery occlusion pressure) that have been 
traditionally used to guide ﬂ uid management are poor 
predictors [22]. CVP has been used for over 40 years to 
guide ﬂ uid management, as an indicator of intravascular 
volume (values <8 cmH2O indicate hemodynamic impair-
ment), even though this relationship has not been proven. 
Other techniques, based on echocardiography, such as 
left ventricular end-diastolic area, or based on thermo-
dilution, such as global end-diastolic volume index, gave 
unsatisfying results [18].
CVP has been used for decades as an indirect measure 
of left ventricle preload as it well approximates the right 
atrial pressure, the major determinant of right ventricle 
ﬁ lling [23,24]. Moreover, changes in CVP in response to 
ﬂ uid challenge tests have been used to predict volume 
responsiveness (target 8 to 12  cmH2O) [13]. However, 
there is increasing evidence that  – due to a series of 
variables, such as venous tone, intrathoracic pressures, 
ventricular compliances and geometry variations, occur-
ring in critically ill patients  – the relationship between 
CVP and right ventricular end-diastolic volume is poor 
and that CVP (absolute or changes) does not correlate 
with volume responsiveness [19]. Similar prob lems were 
Figure 3. Relationship between acidosis/alkalosis and mortality 
in critically ill patients. Relationship between acidosis/alkalosis 
(expressed as hydrogen ion concentration) and mortality in a general 
population of 754 critically ill patients (data recorded at entry to the 
ICU).
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encountered when referring to the pulmonary artery 
occlusion pressure [25,26].
During the past decades a number of dynamic tests 
have been used to dynamically monitor the changes in 
stroke volume after a maneuver that modiﬁ es venous 
return. Th ese methods have been found more reliable 
and less invasive than static ones [24].
Heart–lung interaction during mechanical ventilation 
has been used to evaluate the variations in stroke volume, 
systolic pressure and pulse pressure. Pulse pressure 
variation estimated from the arterial waveform and 
stroke volume variations from pulse contour analysis and 
pulse oximeter plethysmographic waveform variations 
have been found to be reliable predictors of a positive 
response to challenge tests [20]. Th ese hemodynamic 
eﬀ ects are due to the cyclic increase/decrease of intra-
thoracic pressures during mechanical ventilation, aﬀ ect-
ing right and left ventricular preloads and afterloads. 
During insuﬄ  ation, the increased intrathoracic pressures 
reduce right ventricular stroke volume and increase left 
ventricular stroke volume. After the blood pulmonary 
artery transit time (nearly two or three heart beats) even 
the left ventricular preload decreases with a consequent 
stroke volume decrease, which is at its minimum value 
during end expira tion. A ventilation-induced change in 
left ventricle stroke volume of 12 to 13% has been 
reported highly predictive of volume responsiveness [20]. 
Th ese methods, however, have some limitations, 
including the use of tidal volume normalized on ideal 
body weight >8  ml/kg and the absence of either 
spontaneous respiratory activity or arrhythmias [27].
Other dynamic tests have been proposed as reliable 
methods to assess volume replacement responsiveness. 
Th ese include Doppler echocardiography to assess changes 
in aortic ﬂ ow velocity and stroke volume [28,29] and 
changes in venocaval diameter during positive pressure 
ventilation estimated by echocardiography [30-33]. Th e 
end-expiratory occlusion test consists of the interruption 
of mechanical ventilation for 15 seconds to suppress the 
cyclic decrease of cardiac preload during insuﬄ  ations. 
Th e procedure should increase cardiac preload, and an 
increase of 5% in cardiac output and arterial pulse 
pressure should predict ﬂ uid responsiveness [34]. Finally, 
passive leg raising has been proposed as an auto trans-
fusion method independent of mechanical ventila tion 
[35]. In conclusion, there is no gold standard clinically 
available to assess the volume status of the patient. How-
ever, the combined use of diﬀ erent methods may provide, 
in our opinion, an excellent assessment of the hemo-
dynamic status.
Which fl uid?
Th ree kinds of ﬂ uids are available: crystalloids, artiﬁ cial 
colloids and albumin. Although a deﬁ nitive indication of 
the superiority of one ﬂ uid compared with the others is 
still not available, the data obtained in the last few years 
have provided, to diﬀ erent extents, some indications. In 
our opinion, however, discussion of the beneﬁ ts/risks of 
the diﬀ erent solutions only applies when large volumes 
are infused in a relatively short time. Modest infusion, 
such as 1 to 1.5  l over 24 hours, is likely to be clinically 
irrelevant. We may roughly divide the eﬀ ects of the 
infusion into two main arms: eﬀ ects due to the volume of 
the infusion, inde pendent of composition of the solution; 
and eﬀ ects due to the quality of the infusion, dependent 
on the kind of and quantity of solutes present in the ﬂ uid 
replacement.
In critically ill patients, the most general indication for 
large-volume resuscitation is the reﬁ lling of the blood 
vessels (note that the volume infused is not necessarily 
proportionally distributed between the arterial and 
venous trees). Traditionally, we thought that to achieve 
the same intravascular volume the amount of crystalloids 
compared with colloids should be in a ratio of 3:1 [13,36]. 
Th e most recent large trials comparing colloids and 
crystalloids, however, indicate that this ﬁ gure must be 
corrected – the ratio between crystalloids and colloids, to 
obtain the same eﬀ ect, being around 1.5:1 [37-39].
Th e primary eﬀ ect of volume is to alter the acid–base 
status of the blood. Th is eﬀ ect becomes clinically relevant 
when the extracellular ﬂ uid dilution is in the order of 10% 
[40]. We investigated the genesis of acidosis induced by 
crystalloids in theory [41], in vitro [41,42]and in vivo [43]. 
In line with previous results [44-46], we found that 
dilutional acidosis occurs only when the three determi-
nants of the acid–base status [47,48]  – SID, PCO2 and 
total protein content  – are unevenly diluted. If these 
determinants are equally diluted, as during in vitro 
experiments, whatever the com position of the solution 
used to dilute the plasma (from distilled water to normal 
saline), the pH does not change if the system is closed 
because the relative proportions between the pH deter-
minants, equally diluted, are unmodiﬁ ed. If the system in 
vitro is open (by tonometry) to restore the PCO2 to that 
before the dilution, acidosis occurs because the carbon 
dioxide (volatile acid load) content increases back to the 
predilution value while the SID and total protein content 
values remain diluted [41].
Finally, in vivo, the SID of the infused solution becomes 
a determinant to aﬀ ect the acid–base status [43]. When 
the SID is lower than the baseline plasma bicarbonate 
concentration, such as during normal saline infusion, and 
PCO2 is maintained constant, the pH decreases. If the 
SID of the infused solution is equal to the baseline plasma 
bicarbonate, acidosis does not develop. On the contrary, 
if the SID of the infused solution is greater than the 
baseline plasma bicarbonate concentration, the pH tends 
to increase [42,43]. Th e main risks of large crystalloid 
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infusion are therefore edema diﬀ used to the various 
organs [49] and disturbances of the acid–base equili-
brium [40,50,51], depending on the electrolyte compo si-
tion. With this background, normal saline is the worst 
approach for large-volume resuscitation; in fact, with the 
SID of the solution being equal to 0, acidosis is un-
avoidable. Moreover, the chloride load and the relatively 
high osmolarity may increase the burden of the kidney 
with chloride-dependent constriction of the aﬀ erent 
arterioles [52,53].
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